Literature DB >> 1618444

Relevance of a rat model of papillary necrosis and upper urothelial carcinoma in understanding the role of ochratoxin A in Balkan endemic nephropathy and its associated carcinoma.

P H Bach1, N J Gregg, L Delacruz.   

Abstract

Ochratoxin A is nephrotoxic and has been implicated in the genesis of Balkan endemic nephropathy (BEN), a condition that leads to end-stage renal disease and upper urothelial tumours. This compound induces renal parenchymal carcinoma in male mice only, and is not considered to be a potent carcinogen nor is there experimental evidence of its propensity to cause upper urothelial carcinoma. There is, however, evidence that exposure to more than one mycotoxin may be an important factor in the clinical spectrum of BEN. Analgesic nephropathy is clinically different, but is also associated with an upper urothelial carcinoma. The combination of urothelial initiation and an acute papillary necrosis in rats produces upper urothelial carcinoma. This two-stage experimental model offers the potential to assess the role of ochratoxin A in BEN-associated upper urothelial carcinoma under experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618444     DOI: 10.1016/0278-6915(92)90035-j

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  3 in total

Review 1.  Balkan endemic nephropathy: still a mysterious disease.

Authors:  Z Bozić; V Duancić; M Belicza; O Kraus; I Skljarov
Journal:  Eur J Epidemiol       Date:  1995-04       Impact factor: 8.082

Review 2.  Etiology of Balkan endemic nephropathy: a multifactorial disease?

Authors:  D Toncheva; T Dimitrov; S Stojanova
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

3.  Genotoxicity of 12 Mycotoxins by the SOS/umu Test: Comparison of Liver and Kidney S9 Fraction.

Authors:  Maria Alonso-Jauregui; Elena González-Peñas; Adela López de Cerain; Ariane Vettorazzi
Journal:  Toxins (Basel)       Date:  2022-06-10       Impact factor: 5.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.